BWG
ABBV icon

Boomfish Wealth Group’s AbbVie ABBV Stock Holding History

Boomfish Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
1,443
+72
+5% +$15.5K 0.17% 80
2026
Q1 		$298K Buy
1,371
+7
+0.5% +$1.55K 0.16% 77
2025
Q4 		$312K Sell
1,364
-27
-2% -$6.15K 0.17% 78
2025
Q3 		$322K Sell
1,391
-4
-0.3% -$815 0.17% 78
2025
Q2 		$259K Buy
1,395
+4
+0.3% +$743 0.15% 79
2025
Q1 		$291K Buy
1,391
+30
+2% +$5.83K 0.19% 74
2024
Q4 		$242K Sell
1,361
-37
-3% -$6.8K 0.15% 84
2024
Q3 		$276K Sell
1,398
-54
-4% -$10.1K 0.17% 83
2024
Q2 		$249K Sell
1,452
-16
-1% -$2.65K 0.16% 83
2024
Q1 		$267K Buy
1,468
+4
+0.3% +$689 0.18% 81
2023
Q4 		$227K Buy
+1,464
New +$213K 0.16% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boomfish Wealth Group's ABBV Position: Q2 2026 in Review

Boomfish Wealth Group increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $15.5K and bringing the position to 1,443 shares worth $363K. The position accounts for 0.17% of the portfolio, ranked #80.

Boomfish Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Boomfish Wealth Group held 1,443 shares of AbbVie worth $363K as of Q2 2026.
  • Boomfish Wealth Group bought 72 AbbVie shares in Q2 2026, an estimated $15.5K.
  • AbbVie made up 0.17% of Boomfish Wealth Group's portfolio in Q2 2026, its #80 holding.
  • Boomfish Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boomfish Wealth Group's 13F filing for Q2 2026, filed 4 Aug 2026.